(E)-N-(6-morpholinobenzo[d]thiazol-2-yl)-2-(4-(3-chlorobenzyloxy)-2-hydroxybenzylidene)hydrazinecarboxamide

ID: ALA3357973

PubChem CID: 137007047

Max Phase: Preclinical

Molecular Formula: C26H24ClN5O4S

Molecular Weight: 538.03

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(N/N=C/c1ccc(OCc2cccc(Cl)c2)cc1O)Nc1nc2ccc(N3CCOCC3)cc2s1

Standard InChI:  InChI=1S/C26H24ClN5O4S/c27-19-3-1-2-17(12-19)16-36-21-6-4-18(23(33)14-21)15-28-31-25(34)30-26-29-22-7-5-20(13-24(22)37-26)32-8-10-35-11-9-32/h1-7,12-15,33H,8-11,16H2,(H2,29,30,31,34)/b28-15+

Standard InChI Key:  UFGAILIXCJHYAP-RWPZCVJISA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   18.5410  -11.7149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2378  -11.2969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5515  -12.5350    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.9719  -12.5083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2670  -12.9316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9532  -11.6936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.0380   -6.5866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3853  -10.1441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8593  -10.2013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8672  -11.5336    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   27.8180   -7.3018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5685  -10.1489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3734  -11.6901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1560   -9.4452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.6590   -5.1618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0836  -11.2814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1644  -10.8576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7801   -8.0255    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.5967   -8.0177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2559   -5.8742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6639  -10.4622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4411   -5.8775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3476  -10.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0103   -8.7220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3716  -10.0536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9970   -7.3093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2307   -8.0065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2454   -4.4576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4244   -4.4663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6628  -11.2813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0250   -5.1751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6062   -9.4306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2212   -6.5926    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.8266   -8.7185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7894   -9.4355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.0787  -10.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0083   -3.7629    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  6  4  1  0
  5  4  1  0
  1  3  1  0
  2  1  1  0
  6  2  1  0
  3  5  1  0
 29 31  2  0
 23 17  1  0
 35 32  2  0
 19 18  1  0
 33  7  1  0
 13 16  2  0
 17 12  1  0
 12  8  1  0
  7 22  1  0
 23  9  2  0
 21 30  2  0
 11 33  1  0
 12 14  2  0
 16 10  1  0
 15 28  2  0
 20 15  1  0
  9 36  1  0
 27 11  2  0
 30 13  1  0
  8 35  1  0
 22 20  2  0
 25 21  1  0
 36 16  1  0
 10 23  1  0
 34 27  1  0
 19 24  1  0
 32 24  1  0
 24 34  2  0
 31 22  1  0
 28 29  1  0
 11 26  1  0
 36 25  2  0
 26 19  2  0
 30  6  1  0
 29 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3357973

    ---

Associated Targets(Human)

NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-N-SH (1499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 538.03Molecular Weight (Monoisotopic): 537.1238AlogP: 5.23#Rotatable Bonds: 7
Polar Surface Area: 108.31Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.42CX Basic pKa: 0.82CX LogP: 5.60CX LogD: 5.31
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.22Np Likeness Score: -2.11

References

1. Ma J, Chen D, Lu K, Wang L, Han X, Zhao Y, Gong P..  (2014)  Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.,  86  [PMID:25171780] [10.1016/j.ejmech.2014.08.058]

Source